Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Country / region: India Clear all

128 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20043
20053
20062
20076
200812
20093
20106
20113
20122
20132
20153
20174
201811
20199
202011
20218
20225
20235
202410
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61
Active, not recruiting27
Recruiting21
Terminated13
Not yet recruiting2
Unknown status1
Approved for marketing1
No longer available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca29
Eli Lilly and Company13
Pfizer11
Novartis Pharmaceuticals9
Bristol-Myers Squibb8
Boehringer Ingelheim5
Hoffmann-La Roche5
Genzyme, a Sanofi Company4
Merck Sharp & Dohme LLC4
Bayer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung128
Lung Neoplasms25
Carcinoma10
Neoplasm Metastasis6
Kidney Neoplasms3
Neoplasms3
Small Cell Lung Carcinoma3
Bronchial Neoplasms2
Carcinoma, Transitional Cell2
Colonic Neoplasms2

Trials

Showing 51 to 75 of 128. Each trial links to its page on Pharma Observatory.

28 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.